» Articles » PMID: 33569701

The Impact of Immuno-aging on SARS-CoV-2 Vaccine Development

Overview
Journal Geroscience
Specialty Geriatrics
Date 2021 Feb 11
PMID 33569701
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The SARS-CoV-2 pandemic has almost 56 million confirmed cases resulting in over 1.3 million deaths as of November 2020. This infection has proved more deadly to older adults (those >65 years of age) and those with immunocompromising conditions. The worldwide population aged 65 years and older is increasing, and the total number of aged individuals will outnumber those younger than 65 years by the year 2050. Aging is associated with a decline in immune function and chronic activation of inflammation that contributes to enhanced viral susceptibility and reduced responses to vaccination. Here we briefly review the pathogenicity of the virus, epidemiology and clinical response, and the underlying mechanisms of human aging in improving vaccination. We review current methods to improve vaccination in the older adults using novel vaccine platforms and adjuvant systems. We conclude by summarizing the existing clinical trials for a SARS-CoV-2 vaccine and discussing how to address the unique challenges for vaccine development presented with an aging immune system.

Citing Articles

Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV.

Ray S, Narayanan A, Vesterbacka J, Blennow O, Chen P, Gao Y NPJ Biofilms Microbiomes. 2023; 9(1):104.

PMID: 38123600 PMC: 10733305. DOI: 10.1038/s41522-023-00461-w.


The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age.

Orillard E, Spehner L, Mansi L, Bouard A, Falcoz A, Lepiller Q Front Immunol. 2023; 14:1160664.

PMID: 37334387 PMC: 10272422. DOI: 10.3389/fimmu.2023.1160664.


Korean Red Ginseng Potentially Improves Maintaining Antibodies after COVID-19 Vaccination: A 24-Week Longitudinal Study.

Yoon J, Park B, Kim H, Choi S, Jung D Nutrients. 2023; 15(7).

PMID: 37049424 PMC: 10097014. DOI: 10.3390/nu15071584.


"Just right" combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation.

Ananya A, Holden K, Gu Z, Nettleton D, Mallapragada S, Wannemuehler M Immun Ageing. 2023; 20(1):10.

PMID: 36895007 PMC: 9996592. DOI: 10.1186/s12979-023-00332-0.


Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home.

Pozo-Balado M, Bulnes-Ramos A, Olivas-Martinez I, Garrido-Rodriguez V, Lozano C, Alvarez-Rios A Immun Ageing. 2023; 20(1):9.

PMID: 36879319 PMC: 9986663. DOI: 10.1186/s12979-023-00334-y.


References
1.
Goodwin K, Viboud C, Simonsen L . Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2005; 24(8):1159-69. DOI: 10.1016/j.vaccine.2005.08.105. View

2.
Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S . Inflammaging and 'Garb-aging'. Trends Endocrinol Metab. 2016; 28(3):199-212. DOI: 10.1016/j.tem.2016.09.005. View

3.
Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

4.
Vukmanovic-Stejic M, Chambers E, Suarez-Farinas M, Sandhu D, Fuentes-Duculan J, Patel N . Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation. J Allergy Clin Immunol. 2017; 142(3):844-856. PMC: 6127037. DOI: 10.1016/j.jaci.2017.10.032. View

5.
Swift M, Burns A, Gray K, DiPietro L . Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol. 2001; 117(5):1027-35. DOI: 10.1046/j.0022-202x.2001.01539.x. View